ACROBiosystems’ new strategic focus – streamlining the transition from preclinical development to commercialization

BASEL, Switzerland, March 30, 2023 /PRNewswire/ — ACROBiosystems has begun to narrow its focus into helping accelerate the process between preclinical, clinical and commercialization. With over 10 years development, ACROBiosystems continues to surprise and bring new solutions to the…